Fixed-dose combination of calcipotriene/betamethasone dipropionate foam for the management of mild-to-moderate psoriasis in daily clinical practice: a collection of clinical experiences

Anna Campanati, Maria Esposito, Giacomo Caldarola, Sara Cacciapuoti, Gabriella Fabbrocini

Article Type

Case Series

Published

This article reports on a discussion between a group of experts regarding the value of the Cal/BD foam as a topical treatment for mild-to-moderate psoriasis in combination with systemic treatments. Experiences support effectiveness of the Cal/BD foam in daily clinical practice, with an improvement in patient quality of life.

Read more

Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE

Nicoletta Bernardini, Nevena Skroza, Laura Atzori, Cristina Mugheddu, Matteo Megna, Sara Cacciapuoti, Michela Ortoncelli, Maria A Montesu, Antonio Carpentieri, Martino Carriero, Maria G Atzori, Gianmario Addis, Riccardo Balestri, Giulia Rech, Pierluigi Bruni, Manuela Papini, Concetta Potenza

Article Type

Original Research

Published

This multicentre study focuses on psoriasis affecting sensitive areas, its impact on quality of life and the therapeutic response to risankizumab.

Read more

New and emerging oral therapies for psoriasis

Orhan Yilmaz, João Pedro Pinto, Tiago Torres

Article Type

Review

Published

This narrative review synthesizes the emerging oral therapeutic agents for psoriasis, focusing on their mechanisms of action, stages of development and clinical trial results.

Read more

Rapid response on facial psoriasis to bimekizumab: case series

Nicoletta Bernardini, Annunziata Dattola, Giacomo Caldarola, Diego Orsini, Chiara Assorgi, Alessandra D’Amore, Giulia Maretti, Antonio Giovanni Richetta, Ersilia Tolino, Nevena Skroza, Concetta Potenza

Article Type

Case Series

Published

This case series represents the first clinical real-life experience of rapid and successful management of facial psoriasis with bimekizumab in six patients.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.